A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)

Clinical trial NCT04578847 · UNKNOWN

Trial details

NCT number: NCT04578847
Sponsor: National Research Center for Hematology, Russia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Chronic Myeloid Leukemia in Remission BCR-ABL Positive Chronic Myelogenous Leukemia

Start date: 2020-01-15
Primary completion: 2025-01-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.